Sociedad Americana de Hirudoterapia

Continuous postoperative monitoring of cutaneous free flaps using near infrared spectroscopy.

Research article published in Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2007)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosRepez et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2007

Abstract

UNLABELLED: Reliable detection of circulatory compromise threatening free-flap viability is essential for prompt surgical intervention and flap salvage. Numerous techniques have been developed to address the issue of postoperative flap monitoring but none have achieved universal acceptance. Near infrared spectroscopy (NIRS) is a noninvasive technique that allows continuous monitoring of tissue oxygenation and perfusion. It is increasingly recognised to be a reliable method for flap viability assessment. This study was designed to investigate the ability of NIRS to detect and identify microvascular thrombosis endangering flap survival. To our knowledge, this is the first clinical evaluation of NIRS used for continuous monitoring of free flaps. METHODS: Fifty flaps used for autologous breast reconstruction in 48 patients were included in this prospective clinical study. NIRS was employed for 72-h continuous postoperative monitoring. The data were compared to findings of clinical assessments. RESULTS: Ten flaps (20%) developed 13 anastomosis thromboses (two arterial and 11 venous). NIRS detected all cases of flow failure prior to clinical observation with no false positives or negatives. Based on consistent patterns of NIRS parameter changes, it was possible to differentiate between changes caused by arterial and venous thrombosis with accuracy before surgical re-exploration. The salvage rate was 70%. Overall flap viability was 94%. CONCLUSIONS: Continuous NIRS monitoring can reliably detect and identify early stages of arterial and venous thrombosis, and is a credible method for noninvasive postoperative flap surveillance. Based on these findings, we advocate its use for monitoring of flaps with a cutaneous component.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEvaluation StudyJournal Article
Indexed MeSH termsAdultFemaleGraft RejectionGraft SurvivalHumansMammaplastyMiddle AgedPostoperative CarePostoperative ComplicationsProspective StudiesSpectroscopy, Near-InfraredSurgical Flaps

Resumen

Reliable detection of circulatory compromise threatening free-flap viability is essential for prompt surgical intervention and flap salvage. Numerous techniques have been developed to address the issue of postoperative flap monitoring but none have achieved universal acceptance.

Por qué esto importa para la hirudoterapia

Este estudio clínico prospectivo evaluó la espectroscopia de infrarrojo cercano (NIRS) para la monitorización postoperatoria continua de 50 colgajos libres utilizados para reconstrucción mamaria autóloga en 48 pacientes durante 72 horas. La NIRS detectó las 13 trombosis de anastomosis (2 arteriales, 11 venosas) antes de la observación clínica, sin falsos positivos ni negativos, alcanzando una tasa de rescate del 70 % y una viabilidad global del colgajo del 94 %. El resumen concluye que la monitorización continua con NIRS detecta de forma fiable la trombosis arterial y venosa temprana y aboga por su uso para monitorizar colgajos con un componente cutáneo. El resumen no contiene ninguna mención a sanguijuelas, hirudoterapia o cualquier contenido relacionado con sanguijuelas. No existe un vínculo defendible con sanguijuelas a partir de este resumen.

Citación

Continuous postoperative monitoring of cutaneous free flaps using near infrared spectroscopy.

Repez et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2007

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.